(Updated - November 7, 2024 7:35 AM EST)

Baird analyst Brian Skorney lowered the price target on Sarepta Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE